Stockholm - Delayed Quote SEK

Inhalation Sciences Sweden AB (ISAB.ST)

0.6250
+0.0200
+(3.31%)
At close: May 9 at 4:37:47 PM GMT+2
Loading Chart for ISAB.ST
  • Previous Close 0.6050
  • Open 0.5800
  • Bid 0.5800 x --
  • Ask 0.6250 x --
  • Day's Range 0.5800 - 0.6850
  • 52 Week Range 0.3440 - 4.0300
  • Volume 28,737
  • Avg. Volume 194,328
  • Market Cap (intraday) 9.48M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research. The company's products portfolio includes PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents. Inhalation Sciences Sweden AB (publ) was incorporated in 2004 and is headquartered in Huddinge, Sweden.

www.inhalation.se

6

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ISAB.ST

View More

Performance Overview: ISAB.ST

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ISAB.ST
65.08%
OMX Stockholm 30 Index (^OMX)
1.38%

1-Year Return

ISAB.ST
81.06%
OMX Stockholm 30 Index (^OMX)
5.41%

3-Year Return

ISAB.ST
90.14%
OMX Stockholm 30 Index (^OMX)
27.89%

5-Year Return

ISAB.ST
95.08%
OMX Stockholm 30 Index (^OMX)
56.66%

Compare To: ISAB.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ISAB.ST

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    9.10M

  • Enterprise Value

    5.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    1.17

  • Enterprise Value/Revenue

    0.46

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -46.59%

  • Return on Assets (ttm)

    -22.11%

  • Return on Equity (ttm)

    -49.58%

  • Revenue (ttm)

    11.05M

  • Net Income Avi to Common (ttm)

    -5.15M

  • Diluted EPS (ttm)

    -0.3400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.45M

  • Total Debt/Equity (mrq)

    5.66%

  • Levered Free Cash Flow (ttm)

    -805.62k

Research Analysis: ISAB.ST

View More

Company Insights: ISAB.ST

Research Reports: ISAB.ST

View More

People Also Watch